Kidney Care Centre - Surrey

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Stroke1 trial

Phase

• Phase 32 trials

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· Phase 3· Eli Lilly and Company· Source

  Contact: Micheli Bevilacqua (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source